Glenmark Pharmaceuticals Limited (GLENMARK.NS)

Home
GLENMARK.NS
Financials

1646.05 (INR) • At close September 18, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Operating Activities:
Net Income Numbers are in millions	-18,989.96	8,684.51	14,412.46	13,824.75	10,960.76	12,579.82	10,667.95	12,601.52	10,047.45	5,942.83	6,968.76	7,337.15	4,880.91	4,815.53	3,838.974	2,688.813	7,114.988	3,613.183	1,120.716	1,272.942	514.23
Depreciation & Amortization Numbers are in millions	5,819.06	6,112.68	4,867.15	4,435.54	4,171.66	5,465.3	3,540.67	5,765.2	2,691.42	2,599.8	2,167.95	1,270.09	978.28	946.78	1,206.104	1,026.827	716.795	422.589	232.344	164.232	110.93
Deferred Income Tax Numbers are in millions	0	-8,792.91	-7,330.08	-6,228.36	-5,907.43	-9,333.02	-3,675.63	0	0	-2,943.06	486.47	-994.71	1,225.79	-794.14	0	0	0	0	-120.717	-187.225	-59.706
Stock Based Compensation Numbers are in millions	49.62	67.74	79.16	79.39	30.84	1.07	90.64	0	0	3.08	-4.69	28.21	63.98	82.71	0	0	0	0	-0.311	-1.202	-4.593
Change In Working Capital Numbers are in millions	-7,969.53	-10,744.81	-5,612.61	-3,858.38	1,270.64	1,363.41	3,090.6	-8,615.13	-6,077.09	-2,673.09	-2,900.74	-2,530.04	-347.93	3,528.09	-2,093.575	-3,876.639	-3,845.592	-3,262.711	-1,656.898	-1,279.39	-431.675
Accounts Receivables Numbers are in millions	9,695.09	-8,487.44	-5,492.67	-1,179.03	-2,926.79	444.31	1,032.11	171.57	994.23	-4,009.97	-4,594.75	-4,402.72	0	0	0	0	0	0	0	0	0
Inventory Numbers are in millions	-5,138.58	-3,751.69	-2,034.19	-1,338.08	972.56	-4,287.02	1,352.97	-6,143.15	-4,338.97	-3,544.3	-511.92	-435.98	0	0	-782.338	-2,294.862	-1,310.299	-1,121.787	-381.09	-372.614	-377.23
Accounts Payables Numbers are in millions	-7,344.14	1,662.05	847.57	1,604.7	1,527.36	4,494.68	2,008.13	284.53	-251.45	0	0	0	0	0	0	0	0	0	0	0	0
Other Working Capital Numbers are in millions	-5,181.9	-167.73	1,066.68	-2,945.97	1,697.51	711.44	1,737.63	-2,471.98	-1,738.12	871.21	-2,388.82	-952.22	0	0	-1,311.237	-1,581.777	-2,535.293	-2,140.924	-1,275.808	-906.776	-54.445
Other Non Cash Items Numbers are in millions	27,915.55	10,926.71	4,670.44	3,059.21	3,397.66	3,165.13	2,766.31	-3,177.27	-3,213.3	1,887.19	1,819.5	1,385.21	1,242.88	723.64	572.518	320.08	-268.359	159.35	147.196	174.714	104.441
Operating Cash Flow Numbers are in millions	-7,650.63	6,253.92	11,086.52	11,312.13	13,924.13	13,241.71	16,480.54	6,574.32	3,448.48	4,816.75	8,537.25	6,495.91	8,043.91	9,302.61	3,524.021	159.081	3,717.832	932.411	-277.67	144.071	233.627
Investing Activities:
Investments In Property Plant And Equipment Numbers are in millions	-9,148.81	-6,077.63	-7,901.17	-7,747.58	-9,313.73	-12,371.71	-10,446.4	-7,485.29	-8,902.72	-5,442.75	-3,766.25	-4,709.61	-2,853.96	-4,011.6	-3,958.007	-9,744.522	-5,227.573	-2,797.043	-2,506.81	-2,048.036	-656.574
Acquisitions Net Numbers are in millions	54,516.89	803.47	112.52	994.33	1,560.31	6,218.89	219.16	151.2	16.22	0	0	0	0	0	0	0	0	0	0	152.8	0
Purchases Of Investments Numbers are in millions	-1.29	-60.08	-400.18	-29.08	-1,610.31	-150	0	0	0	0	0	0	0	0	0	0	0	0	-44.871	-4.661	-1.178
Sales Maturities Of Investments Numbers are in millions	70.51	50	300	-965.25	50	85.55	0	0	0	0	0	0	0	0	0	6.942	0	9.751	0	0.036	0
Other Investing Activites Numbers are in millions	-166.32	-0.67	4,556.03	995.22	1,478.56	-772.66	312.97	361.84	101.01	42.38	85.21	69.05	76.1	342.1	88.881	235.976	128.998	99.477	98.68	-10.583	252.337
Investing Cash Flow Numbers are in millions	45,437.3	-5,284.91	-3,332.8	-6,752.36	-7,835.17	-6,989.93	-10,133.43	-7,123.45	-8,801.71	-5,400.37	-3,681.04	-4,640.56	-2,777.86	-3,669.5	-3,869.126	-9,501.604	-5,098.575	-2,687.815	-2,453.001	-1,910.444	-405.415
Financing Activities:
Debt Repayment Numbers are in millions	-31,683.7	-5,132.21	-30,191.45	-17,108.93	-8,375.63	-10,506.08	-8,693.93	-20,954.98	-13,395.41	-6,906.58	-6,275.93	-2,557.16	-8,088.13	-10,925.95	-5,250.473	0	-9.445	-78.727	0	-249.719	0
Common Stock Issued Numbers are in millions	12	0	10,118.54	0	0	4,435.24	0	2.64	9,354.95	20.34	125.01	64.86	35.56	40.86	4,142.78	350.586	2,001.91	311.343	3.668	102.38	508.185
Common Stock Repurchased Numbers are in millions	0	0	16,368.83	0	0	-318.85	0	0	0	9,922.27	6,379.64	5,567.56	-327	-232.25	4,975.536	0	-230.231	1,774.986	0	3,209.128	0
Dividends Paid Numbers are in millions	-1,177.52	-1,366.06	-926.95	-704.47	-685.54	-678.81	-678.82	-678.05	-678.53	-634.65	-631.91	-642.56	-126.09	-125.82	-117.996	0	-171.753	-102.247	-179.59	-83.446	-76.224
Other Financing Activities Numbers are in millions	-344.62	5,723.71	-573.88	13,395.61	4,614.54	-318.85	4,687.76	27,061.9	11,704.95	-409.15	-576.97	-480.35	4,891.73	6,887.04	-3,049.365	8,141.691	297.782	-148.386	2,680.799	-12.136	-217.204
Financing Cash Flow Numbers are in millions	-33,893.45	-774.56	-5,204.91	-4,417.79	-4,446.63	-7,387.35	-4,684.99	5,431.51	6,985.96	1,992.23	-980.16	1,952.35	-3,613.93	-4,356.12	700.482	8,492.277	1,888.263	1,756.969	2,504.877	2,966.207	214.757
Other Information:
Effect Of Forex Changes On Cash Numbers are in millions	176.79	123.8	175.5	136.22	97.64	-1,835.21	107.8	-2,889.95	-698.87	-1,719.25	-1,979.91	-956.61	-400.08	-364.1	0	0	0	0	9.023	-8.334	-7.413
Net Change In Cash Numbers are in millions	1,897.6	325	2,724.31	278.2	1,739.97	-2,970.78	1,769.92	1,992.43	933.86	-310.64	1,896.14	2,851.09	1,252.04	912.89	355.377	-850.246	507.52	1.565	-216.771	1,191.5	35.556
Cash At End Of Period Numbers are in millions	16,594.56	14,430.26	14,105.26	11,380.95	11,102.75	9,362.78	12,333.56	10,563.64	8,571.21	7,637.35	7,947.99	6,051.85	3,200.76	1,948.72	1,070.2	714.823	1,565.069	1,057.549	1,055.984	1,272.755	81.255

Glenmark Pharmaceuticals Limited

NSE:GLENMARK.NS Add to watchlist

NSE:GLENMARK.NS